Amwell (AMWL) Misses Q4 EPS by 73c

Amwell (NYSE: AMWL) reported Q4 EPS of ($0.99), $0.73 worse than the analyst estimate of ($0.26). Revenue for the quarter came in at $79.2 million versus the consensus estimate of $78.08 million.

For earnings history and earnings-related data on Amwell (AMWL) click here.

You May Also Be Interested In

• AngioDynamics (ANGO) Tops Q4 EPS by 2c ; Offers Guidance
• Wells Fargo sees machinery sector recovery shifting to demand-driven
• Bank of America (BAC) Tops Q2 EPS by 9c, Beats on Revenue